Doribax Side Effects May Increase Death Risk for Pneumonia Patients: FDA
The FDA warns that the drug Doribax should not be used on patients with ventilator-acquired pneumonia due to a higher risk of death.
The FDA warns that the drug Doribax should not be used on patients with ventilator-acquired pneumonia due to a higher risk of death.
A new study raises concerns about unreported side effects with antimicrobial submissions